Has Arjun Bal received payments from drug or device companies?

Yes. Drug and device makers reported $11,366 in general payments to Arjun Bal across 220 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arjun Bal did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arjun Bal come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arjun Bal

Dermatology · Trenton, MINPI 1154068864

Payments from drug & device makers

$11,366in general payments, 2019–2025

Across 220 payments — averaging $51.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$2K
AbbVie$1K
Regeneron Healthcare Solutions, Inc.$910
Dermavant Sciences, Inc.$879
Johnson & Johnson$829
UCB, Inc.$772
plus $5K from 16 others

$1,683in research payments, 2019–2025

Across 12 payments — averaging $140.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Regeneron$2K

What the payments were for

Food & beverage$11,22199%
Education$1451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	24	$1,504
AbbVie	28	$1,293
Regeneron Healthcare Solutions, Inc.	17	$910
Dermavant Sciences, Inc.	12	$879
Johnson & Johnson	24	$829
UCB, Inc.	13	$772
Galderma Laboratories, L.p.	7	$623
Novartis	28	$537
Boehringer Ingelheim	6	$475
Lilly USA, LLC	11	$464
Sun Pharmaceutical Industries Inc.	5	$462
LEO Pharma Inc.	8	$454
E.r. Squibb & Sons, L.L.C.	3	$373
Arcutis Biotherapeutics, Inc.	3	$371
Kerecis Limited	7	$361
Incyte Corporation	10	$358
Pfizer	4	$276
Janssen Scientific Affairs, LLC	2	$154
Organon	2	$112
Biofrontera Inc.	3	$79
Almirall LLC	1	$39
Amgen	2	$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,366 in reported general payments places this provider in the 80th percentile of 404 dermatology providers in Michigan.

See all dermatology providers in Michigan →

Other dermatology in Trenton

Johann GudjonssonAnn Arbor$15.9M
Ali MoiinTroy$9.9M
Linda Stein GoldWest Bloomfield$7.5M
Wendy McFaldaClarkston$3.6M
Kristi HawleyCaledonia$2.5M
Brent BoyceSebewaing$2.2M
David AltmanWarren$1.9M
Christofer BuattiAuburn Hills$1.6M
Mio NakamuraAnn Arbor$1.4M
George MurakawaTroy$1.3M

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →